Favit-Van Pelt Antonella R. 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Feb 16, 2023
Insider Transaction Report
Form 4
Favit-Van Pelt Antonella R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-14+1,463,000→ 1,463,000 totalExercise: $0.31Exp: 2033-02-13→ Common Stock (1,463,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. The options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter so that all of the options will be vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting period.